Telehealth appointments improve follow-up care in patients with heart failure
Kaiser Permanente study is the first to compare early telehealth approach to early in-person follow-up to prevent hospital readmissions.
Kaiser Permanente
Division of Research Spotlight
The Kaiser Permanente Division of Research conducts, publishes, and disseminates epidemiologic and health services research to improve the health and medical care of Kaiser Permanente members and society at large. We seek to understand the determinants of illness and well-being, and to improve the quality and cost-effectiveness of health care. Currently, DOR’s 550-plus staff is working on more than 350 epidemiological and health services research projects.
New virtual, innovative clinical trial for adults at high risk for respiratory illnesses
Kaiser Permanente researchers will see if a drug used to reduce risk of heart attack and stroke can also prevent or reduce complications from viral respiratory illnesses in older adults with heart disease.
COVID-19 clinical studies ramp up quickly at Kaiser Permanente Northern California
In the race to find safe and effective treatments for seriously ill patients with COVID-19, Kaiser Permanente Northern California (KPNC) is enrolling patients in nationwide clinical trials and pursuing other innovative treatment options.
Population-level estimates show wide age range of adults hospitalized with COVID-19
A JAMA study, using data on patients hospitalized in March from all 21 Kaiser Permanente Northern California hospitals, is one of the first U.S. studies to look at overall hospitalization admissions of COVID-19 patients.
KP Research Radio: A promising treatment for ovarian cancer
5 Questions for…Dr. Michael A. Bookman, co-leader of a clinical trial that could provide an important new treatment option for women with advanced gynecological cancers.
World’s Most Impactful Researchers List Includes Kaiser Permanente Northern California Scientist and Oncologist
Alan Go, MD, of the Kaiser Permanente Division of Research, and Kaiser Permanente Northern California oncologist Louis Fehrenbacher, MD, are among the less than 400 people named as Highly Cited Researchers in clinical medicine for 2017 by Clarivate Analytics. The annual list recognizes investigators whose research ranks in the top 1 percent most cited works in their field, indicating exceptional scientific impact.
